
Sun Pharma European partner Philogen pulls EMA application for skin cancer drug Nidlegy
Siena: Sun Pharma European partner Philogen S.p.A has voluntarily withdrawn the application for marketing authorization to the European Medicines Agency (EMA) for Nidlegy, a biological investigational medicinal product which is intended to be used for the …